Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesLate Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer
Journal of Clinical Oncology, 09/01/09
Efstathio JA et al. – Rates of significant late pelvic toxicity for patients completing combined–modality therapy for invasive bladder cancer and retaining their native bladder are low.
Related Articles
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS Trial
Journal of Clinical Oncology, 10/30/09
Relevance Score: 47%
Percutaneous Pelvic Fixation Using Working Portals in a Circumferential Pelvic Antishock Sheet
Journal of Orthopaedic Trauma, 10/12/09
Relevance Score: 46%
T-Cell Recognition of Prostatic Peptides in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
The Journal of Urology, 10/14/09
Relevance Score: 45%
A validated self-administered female pelvic floor questionnaire
International Urogynecology Journal, 10/06/09
Relevance Score: 45%
The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients
Cancer Chemotherapy and Pharmacology, 10/07/09
Relevance Score: 44%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09
XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Article Search
Sponsor